Literature DB >> 24127280

Large scale study of HPV genotypes in cervical cancer and different cytological cervical specimens in Thailand.

Jira Chansaenroj1, Pairoj Junyangdikul, Teeraporn Chinchai, Sukumarn Swangvaree, Anant Karalak, Nobuhiro Gemma, Yong Poovorawan.   

Abstract

Identification of high-risk HPV genotypes in patients is essential for vaccination and prevention programs while the geographic distribution of cervical cancer varies widely. HPV 16 is the major cause of cervical cancer followed by HPV 18, HPV 31, HPV 52, or HPV 58 depending on geographic area. In this study, the distribution of HPV genotypes in cervical specimens from women living in Thailand was analyzed by HPV testing with electrochemical DNA chip and PCR direct sequencing. The 716 specimens were grouped according to their cytological grades; 100 normal, 100 low-grade squamous intraepithelial lesions, 100 high grade squamous intraepithelial lesions, and 416 specimens of cervical cancer. The results showed that HPV 16, HPV 18, HPV 52, and HPV 58 are the most common HPV genotypes in Thailand, respectively. With respect to age, women below the age of 26 years were almost negative for high-risk HPV DNA exclusively. Conversely, high prevalence of high-risk HPV DNA and abnormal cytology were usually found in women between 26 and 45 years while cervical cancer was detected mainly in women above the age of 45 years. To increase protection efficiency, a vaccine including HPV 52 and HPV 58 should be offered to Asian women, and primary HPV screening should start at 26-30 years of age.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  DNA chip; Thailand; multiple infections

Mesh:

Substances:

Year:  2013        PMID: 24127280     DOI: 10.1002/jmv.23769

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker.

Authors:  Phetploy Rungkamoltip; Sasithon Temisak; Kitiya Piboonprai; Deanpen Japrung; Pattanapong Thangsunan; Saranya Chanpanitkitchot; Woraphot Chaowawanit; Nutthaporn Chandeying; Siriwan Tangjitgamol; Tawin Iempridee
Journal:  Exp Biol Med (Maywood)       Date:  2020-12-13

2.  Parents' preferences and willingness-to-pay for human papilloma virus vaccines in Thailand.

Authors:  Surachat Ngorsuraches; Kornwan Nawanukool; Krittin Petcharamanee; Ungkanit Poopantrakool
Journal:  J Pharm Policy Pract       Date:  2015-07-22

3.  Prevalence and correlates of HPV among women attending family-planning clinics in Thailand.

Authors:  Morgan A Marks; Swati Gupta; Kai-Li Liaw; Amha Tadesse; Esther Kim; Chailert Phongnarisorn; Virach Wootipoom; Pissamai Yuenyao; Charoen Vipupinyo; Sungwal Rugpao; Somchai Sriplienchan; Patti E Gravitt; David D Celentano
Journal:  BMC Infect Dis       Date:  2015-03-27       Impact factor: 3.090

4.  Comparison of Human Papillomavirus Detection in Urine and Cervical Samples Using High-Risk HPV DNA Testing in Northern Thailand.

Authors:  Surapan Khunamornpong; Jongkolnee Settakorn; Kornkanok Sukpan; Suree Lekawanvijit; Narisara Katruang; Sumalee Siriaunkgul
Journal:  Obstet Gynecol Int       Date:  2016-12-22

5.  Distribution of Human Papillomavirus 52 and 58 Genotypes, and Their Expression of p16 and p53 in Cervical Neoplasia.

Authors:  Tae Eun Kim; Hwal Woong Kim; Kyung Eun Lee
Journal:  Korean J Pathol       Date:  2014-02-25

6.  Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.

Authors:  Surapan Khunamornpong; Jongkolnee Settakorn; Kornkanok Sukpan; Prapaporn Suprasert; Jatupol Srisomboon; Suthida Intaraphet; Sumalee Siriaunkgul
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.